First Fill

09/01/2016 - "The aim of this study was to measure the first-fill rate of newly prescribed asthma medications for new patients presenting to a pediatric subspecialty asthma clinic, determine potential risk factors for not filling medication, and evaluate change in lung function at follow-up. "
06/01/2009 - "The goal of the study was to examine the proportion of patients who fill a new prescription for an asthma medication and analyze characteristics associated with this first-fill. "
06/01/2009 - "The overall first-fill rate for new asthma medications was 78%. "
06/01/2009 - "Little is known about first-fill adherence with asthma medications and the factors for no-fill. "
06/01/2009 - "Lower copay and oral administration: predictors of first-fill adherence to new asthma prescriptions."

01/01/2023 - "This study compared the risk of ischemic stroke/SE among patients with NVAF who discontinued DOACs following the first fill ("one-and-done") relative to patients who continued DOACs beyond the first fill ("continuers"). "
01/01/2023 - "Patients with NVAF who abandoned the first DOAC fill had significantly higher risk of ischemic stroke/SE compared to patients who continued therapy beyond the first fill. "

08/01/2009 - "The IMS longitudinal prescription database was used to evaluate compliance (mean medication possession ratio), persistence (days until a gap >90 days between prescriptions occurred) and cumulative drug availability (ratio of drug supply and days between first fill date and the end of the study) among patients taking weekly risedronate or monthly ibandronate over a 12-month period using three retrospective cohorts: overall sample, new to osteoporosis therapy, and new to osteoporosis therapy after initial market availability. "

01/01/2016 - "Average monthly adherence to COPD maintenance medications was low, peaking at 57% in the month after first fill and decreasing to 35% within 6 months. "
01/01/2013 - "Eligible patients were ≥40 years old, had ≥2 years of continuous enrollment, ≥1 CB (ICD-9-CM code 491.xx) hospitalization or emergency department (ED) visit or ≥2 office visits between 1/1/2004 and 5/31/2011, and had ≥2 pharmacy fills for COPD medications during follow-up (first fill served as the index date). "

04/01/2009 - "Predictors of first-fill adherence for patients with hypertension."
06/01/2011 - "Significant factors associated with first-fill failure were new diagnosis of hypertension, new antihypertensive agent, higher co-payment, and enrollment in a health maintenance organization or preferred provider organization. "